Inventor · disambiguated record
Gadi Gazit-Bornstein
Also filed as: GAZIT-BORNSTEIN GADI
7 granted patents·5 pending applications·98 citations·filing 2003–2015
82Inventor score
Top patents by PatentIndex Score
12 records- 0195US7423128B2Anti-properdin antibodies, and methods for making and using sameAMGEN FREMONT INC·Filed 2004·Granted Sep 9, 2008·82 cites·34 claims
- 0284US7939637B2Insulin-like growth factor antibodies and uses thereofMEDIMMUNE LTD·Filed 2006·Granted May 10, 2011·8 cites·18 claims
- 0383US7754859B2Targeted binding agents directed to PDGFR-alpha and uses thereofASTRAZENECA AB·Filed 2007·Granted Jul 13, 2010·7 cites·18 claims
- 0460US8697664B2Targeted binding agents directed to PDGRF-alpha and uses thereofLAING NAOMI·Filed 2010·Granted Apr 15, 2014·1 cites·23 claims
- 0557US9181336B2Binding proteins specific for insulin-like growth factors and uses thereofMEDIMMUNE LTD·Filed 2013·Granted Nov 10, 2015·0 cites·12 claims
- 0657US2009324601A1Targeted binding agents directed to pdgfr-alpha and uses thereofASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 0752US9796779B2Binding proteins specific for insulin-like growth factors and uses thereofMEDIMMUNE LTD·Filed 2015·Granted Oct 24, 2017·0 cites·2 claims
- 0852US2007014720A1Antibodies directed to CD20 and uses thereofGAZIT-BORNSTEIN GADI·Filed 2006·Application pending·0 cites
- 0951US2010196398A1Targeted binding agents directed to cd105 and uses thereofMEDIMMUNE LLC·Filed 2009·Application pending·0 cites
- 1050US2011129412A1Antibodies Directed to CD20 and Uses ThereofASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 1147US8410058B2Methods of using insulin-like growth factor antibodies to treat tumorsRAEBER OLIVIA·Filed 2011·Granted Apr 2, 2013·0 cites·20 claims
- 1244US2004141969A1Method for the treatment of nephritis using anti-PDGF-DD antibodiesFiled 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gadi Gazit-Bornstein files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →